1 2 3 4 5 6 7
читать далее ... in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation, 2003, 108 (10), 1278-1290. 4. Weinberger J. Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke. Drugs, 2005, 65 (4), 461-471. 5. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N. Engl. J Med. 1989, 321, 129-135. 6. Ridker P., Cook N., Min Lee 1. et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N. Engl. J. Med., 2005, 352. 7. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002, 324, 71-86. 8. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group. Lancet, 1991, 338, 1345-1349. 9. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet, 1996, 348, 1329-1339. 10. Peters R., Mehta S., Fox K. et al. Effects of aspirin dose when used atone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation, 2003, 108 (14), 1682-1687. 11. Diener H.-C., Bogousslavsky J., Brass L. et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet, 2004, 364, 331-337. 12. Hankey G. Ongoing and planned trials of antiplatelet therapy in the acute and long-term management of patients with ischaemic brain syndromes: setting a new standard of care. Cerebrovasc. Dis.. 2004, 17 (Suppl. 3), 11-16. 13. Payne D., Jones С., Hayes P. et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation, 2004, 109 (12), 1476-1481. 14. Diener H., Cunha L., Forties C. et al. European Stroke Prevention Study: 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J. Neurol. Sci., 1996, 143, 1-13. 15. Caplain H. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers. Cerebrovasc. Dis., 2005, 19 (4), 214-219. 16. Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atnal fibrillation: analysis of pooled data from 3 randomized trials. Arch. Intern. Med., 1997, 157, 1237-1240. 17. van WalravenИсточник: Моисеев С.В. Клиническая фармакология и терапия. 2005. №3. С. 65-70